Article Information
History
- April 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- David Patrick Kateete1,§,*,
- Monica M Mbabazi1,
- Faith Nakazzi1,
- Fred A Katabazi1,
- Edgar Kigozi1,
- Willy Ssengooba2,
- Lydia Nakiyingi3,4,
- Sharon Namiiro5,
- Alphonse Okwera5,
- Moses L Joloba1 and
- Adrian Muwonge6,§,*
- 1Department of Immunology & Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
- 2BSL-3 Mycobacteriology Laboratory, Department of Medical Microbiology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
- 3Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
- 4Infectious Diseases Institute, Makerere University College of Health Sciences, Mulago Hospital Complex, Kampala, Uganda
- 5TB Clinics, Mulago National Referral Hospital, Kampala, Uganda
- 6Division of Genetics and Genomics, Division of Infection and Immunity, The Roslin institute, University of Edinburgh, Edinburg, UK
- ↵*Correspondence to dkateete{at}chs.mak.ac.ug & adrian.muwonge{at}roslin.ed.ac.uk
↵§ Contributed equally
Posted April 29, 2020.
Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy
